Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73

NCT01592214 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

NIH

Sponsor class

Conditions

Staphylococcal Infection

Interventions

OTHER: Placebo
DRUG: XF-73 in 2% Klucel gel
DRUG: XF-73 in 4% Klucel gel

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)